ClinicalTrials.Veeva

Menu

Impact of Blueberries on Uric Acid and Quality of Life

University of Mississippi logo

University of Mississippi

Status

Completed

Conditions

Hyperuricemia

Treatments

Dietary Supplement: Blueberry Powder
Other: Placebo Powder

Study type

Interventional

Funder types

Other

Identifiers

NCT01532622
2011-0218

Details and patient eligibility

About

The purpose of this study is to determine the impact of blueberries on uric acid in patients with hyperuricemia that are not receiving uric acid pharmacotherapy. The central hypothesis the investigators propose is that daily blueberries added to a pre-existing diet will promote uric acid lowering and improve quality of life without detriment to vital signs.

Enrollment

30 patients

Sex

All

Ages

18 to 88 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18 years or older
  • Uric acid > 6.0 mg/dL

Exclusion criteria

  • Current moderate-to-severe symptomatic gout
  • Currently receiving gout pharmacotherapy
  • Current participation in another clinical trial
  • Documented non-compliance or consistent missed appointments
  • Women who are pregnant or nursing

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

30 participants in 2 patient groups, including a placebo group

Blueberry Powder
Active Comparator group
Description:
Patients will take 30 grams of blueberry powder daily for up to 30 days.
Treatment:
Dietary Supplement: Blueberry Powder
Placebo Powder
Placebo Comparator group
Description:
Patients will take 30 grams of placebo powder daily for up to 30 days.
Treatment:
Other: Placebo Powder

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems